Haleon plc
HLN
株式のランク
#13675
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
株価
$5.01
時価総額
$440.81M
変化（1日）
0.13%
変化（1年）
6.41%
国
GB
取引 Haleon plc (HLN)
カテゴリー
Healthcare
Haleon plc（HLN）の株価履歴
終値の最高値: $4.68 （2026-10-01）
終値の最安値: $3.48 （2022-07-01）
終値の最安値: $3.48 （2022-07-01）
Haleon plc の株価履歴（2022 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -0.76% |
| 2025 | 2.79% |
| 2024 | 16.19% |
| 2023 | 13.23% |
| 2022 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.56 | 21.57% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $223.41 | 30.46% |
CH
|
|
| $18.47 | -3.81% |
IN
|
